These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5511214)

  • 61. Treatment of muscular dystrophy with laevadosin.
    Das Gupta A
    J Indian Med Assoc; 1969 Oct; 53(8):390-2. PubMed ID: 5369189
    [No Abstract]   [Full Text] [Related]  

  • 62. [The behavior of some indices of carbohydrate metabolism on subjects with progressive muscular dystrophy subjected to muscular work].
    Pirrelli A
    Boll Soc Ital Biol Sper; 1965 Apr; 41(8):396-7. PubMed ID: 5875558
    [No Abstract]   [Full Text] [Related]  

  • 63. [Membrane theory of the pathogenesis of progressive muscular dystrophy].
    Badalian LO; Temin PA; Il'in IL; Kovaleva MIu; Dzutova ED
    Klin Med (Mosk); 1982 Oct; 60(10):13-6. PubMed ID: 6757558
    [No Abstract]   [Full Text] [Related]  

  • 64. [Free amino acids in the skeletal muscles, blood and urine of healthy persons and of patients with progressive muscular dystrophy].
    Mönch E; Kirsten E; Heyck H
    Monatsschr Kinderheilkd (1902); 1967 Apr; 115(4):288-9. PubMed ID: 5592537
    [No Abstract]   [Full Text] [Related]  

  • 65. Incorporation of glycine-I-C14 into nucleic acids and proteins of mice with hereditary muscular dystrophy.
    COLEMAN DL; ASHWORTH ME
    Am J Physiol; 1959 Oct; 197():839-41. PubMed ID: 13811144
    [No Abstract]   [Full Text] [Related]  

  • 66. [Long term observations in muscular dystrophy. Therapeutic influence of disease course in progressive muscular dystrophy (8 long term observations)].
    Schlenska GK; Kleine TO
    Med Welt; 1980 Jun; 31(25):940-4. PubMed ID: 6775171
    [No Abstract]   [Full Text] [Related]  

  • 67. [Intensity of renewal of the protein fractions of myofibrils in the skeletal muscles and heart of rabbit in experimental muscular dystrophy (E-avitaminosis)].
    Pkhakadze GA
    Ukr Biokhim Zh; 1967; 39(4):381-5. PubMed ID: 5603088
    [No Abstract]   [Full Text] [Related]  

  • 68. [On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity].
    Canani MB; Rea F; Capasso DA
    Boll Soc Ital Biol Sper; 1965 Aug; 41(16):901-4. PubMed ID: 5880029
    [No Abstract]   [Full Text] [Related]  

  • 69. The functional staging of Duchenne muscular dystrophy using in vivo 31P MR spectroscopy.
    Ikehira H; Nishikawa S; Matsumura K; Hasegawa T; Arimizu N; Tateno Y
    Radiat Med; 1995; 13(2):63-5. PubMed ID: 7667509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 72. [Therapy of progressive muscular dystrophy using high insulin doses].
    Richter I; Pathenheimer F; Plath C
    Kinderarztl Prax; 1972 May; 40(5):216-9. PubMed ID: 5055820
    [No Abstract]   [Full Text] [Related]  

  • 73. [Anabolic steroid hormones and progressive muscular dystrophy].
    Beckmann R
    Dtsch Med Wochenschr; 1972 Feb; 97(6):213. PubMed ID: 5058209
    [No Abstract]   [Full Text] [Related]  

  • 74. Muscular dystrophy: potassium exchange in residual muscle.
    SHY GM; CUMMINGS DJ; BERG L; HORVATH B
    J Appl Physiol; 1955 Jul; 8(1):33-6. PubMed ID: 13242488
    [No Abstract]   [Full Text] [Related]  

  • 75. Calcium homeostasis in dystrophic muscle.
    Ruegg UT; Gillis JM
    Trends Pharmacol Sci; 1999 Sep; 20(9):351-2. PubMed ID: 10515794
    [No Abstract]   [Full Text] [Related]  

  • 76. Fat deposition in musculature of the genetically dystrophic chicken.
    JORDAN JP; KRATZER FH; JOHNSON AM; FREEMAN RL
    Proc Soc Exp Biol Med; 1959 Jul; 101(3):449-51. PubMed ID: 13675276
    [No Abstract]   [Full Text] [Related]  

  • 77. Potassium permeability in isolated skeletal muscle from mice with muscular dystrophy.
    Lipicky RJ; Hess J
    Am J Physiol; 1974 Mar; 226(3):592-6. PubMed ID: 4817411
    [No Abstract]   [Full Text] [Related]  

  • 78. [Myoglobin and progressive muscular dystrophy].
    Sudaka P; Martin P; Rovinski J; Martin M
    Nouv Presse Med; 1972 Nov; 1(42):2838. PubMed ID: 4663746
    [No Abstract]   [Full Text] [Related]  

  • 79. Muscular dystrophy: cation concentrations in residual muscle.
    HORVATH B; BERG L; CUMMINGS DJ; SHY GM
    J Appl Physiol; 1955 Jul; 8(1):22-30. PubMed ID: 13242486
    [No Abstract]   [Full Text] [Related]  

  • 80. [Progressive muscular dystrophy].
    Tsuji S; Kato F; Osawa K
    Naika; 1967 Jun; 19(6):1301-3. PubMed ID: 4865513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.